Week in Review | International Myeloma Foundation

teclistamab bispecific antibody

Week in Review

November 16

What Patients Need to Know About Tecvayli (teclistamab-cqyv)

2022 ASH Abstracts Preview

Week in Review

November 10

A Big Picture Preview of the 2022 ASH Annual Meeting

Lab technician holding vaccine vial

Week in Review

October 27

Tecvayli Bispecific Engager Approved by FDA for Treatment of Relapsed Myeloma; COVID-19 Subvariants Raise Concerns of Winter Surge

IMF 6th Annual Asian Myeloma Network Summit

Week in Review

October 20

The IMF’s 6th Annual Asian Myeloma Network Summit in Singapore: A Major Success

couple on a covid-19 vacation

Week in Review

October 13

Unwinding in the Time of COVID-19

lady getting vaccinated

Week in Review

September 22

Drawing Strength from Amanda Gorman’s ‘An Ode We Owe’

blood testing lab

Week in Review

September 14

Myeloma Moonshot: Ahead of Schedule

COVID-19 booster shot

Week in Review

September 1

Will Amazon Deliver Your Healthcare Needs?

CDC COVID-19 guidance

Week in Review

August 18

Making Sense of the CDC’s New COVID-19 Guidelines

support group myeloma community

Week in Review

August 4

Why Belonging to a Myeloma Community is Important

covid-19 safety myeloma patients

Week in Review

July 21

A New Era of COVID-19

support group members holding hands during a meeting

Week in Review

July 14

What Does the Future Hold for Myeloma Patients?

Subscribe to Week in Review

Give Where Most Needed